News | EP Lab | June 05, 2018

Philips Acquires Electrophysiology Ablation Image-Guidance Company EPD

EPD’s cardiac imaging and navigation system helps EPs navigate the heart by generating a detailed 3-D image of the cardiac anatomy

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A panoramic real-time visualization of pulmonary vein isolation (PVI) procedure from the DURABLE-I trial using the EDP ablation image guidance system. It highlights a gap (red line) in the left atrial appendage (LAA) ridge that was correctly identified by EPD D700 system, yet undiagnosed by either electrical isolation test or adenosine infusion.

A panoramic real-time visualization of pulmonary vein isolation (PVI) procedure from the DURABLE-I trial using the EDP ablation image guidance system. It highlights a gap (red line) in the left atrial appendage (LAA) ridge that was correctly identified by EPD D700 system, yet undiagnosed by either electrical isolation test or adenosine infusion.

 

June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in catheter ablation procedures for cardiac arrhythmias, for $292 million Euros. EPD’s cardiac imaging and navigation system helps electrophysiologists (EPs) navigate the heart by generating a detailed 3-D image of the cardiac anatomy, while also pinpointing the location and orientation of catheters during the diagnostic and therapeutic procedures for cardiac arrhythmias. This new technology has the potential to simplify navigation and treatment, immediately assess the treatment result and ultimately enhance procedure efficacy. 

Watch a video showing how this technology helps guide EP ablation procedures. 

Watch a video showing how the system illustrated ablation points and can show gaps between lesions.

The acquisition will complement Philips’ portfolio of interventional imaging systems, smart catheters, planning and navigation software and services, and will allow the company to introduce new solutions in the 2 billion Euro market for image-guided treatment of cardiac arrhythmias, which is growing at a double-digit rate, according to Philips. The company will acquire EPD for an upfront cash consideration of 250 million Euros and deferred, milestone dependent payments. In connection with these contingent payments, the company expects to recognize a provision of approximately 210 million Euros upon completion of the transaction. The transaction, which is subject to customary closing conditions, is expected to be completed in July 2018. 

“I am very pleased that Philips will become the home for our innovation, our business and our people,” said Professor Shlomo Ben-Haim, founder and chairman of EPD Solutions. “Philips’ expertise and leadership in interventional imaging and navigation is an excellent strategic fit with EPD. I am convinced that as part of Philips, we will be able to grow EPD and help many electrophysiologists and patients worldwide, as we aim to reduce procedure costs, simplify navigation and treatment, and ultimately improve procedure efficacy.”
The combination of Philips’ interventional imaging systems, such as Azurion, and EPD’s cardiac imaging and navigation system provides the maps and data used by EPs to guide various catheters to locate and treat cardiac arrhythmias. 

EPD’s system, which obtained European CE marking in February, 2018, is based on proprietary software algorithms and single-use electromagnetic sensors, used in conjunction with standard electrophysiology catheters. The system has been installed at several leading hospitals across Europe. A U.S. Food and Drug Administration 510(k) premarket review for the system is currently under review. The system is not available for sale in the U.S.

Upon completion of the transaction, EPD and its employees will become part of Philips’ Image-Guided Therapy business. Professor Shlomo Ben-Haim, who has a proven track record in building successful medical device businesses, will continue to support Philips to build a new business based on this acquisition.

For more information: www.usa.philips.com

Related Content

Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Ablation Systems | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically
Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...
CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
Overlay Init